2-98370042-C-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001298.3(CNGA3):c.67C>T(p.Arg23*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,613,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001298.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- achromatopsia 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Illumina, PanelApp Australia
- CNGA3-related retinopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- achromatopsiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000263  AC: 4AN: 152122Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000358  AC: 9AN: 251056 AF XY:  0.0000368   show subpopulations 
GnomAD4 exome  AF:  0.0000198  AC: 29AN: 1461704Hom.:  0  Cov.: 31 AF XY:  0.0000151  AC XY: 11AN XY: 727124 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000263  AC: 4AN: 152122Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74294 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Achromatopsia 2    Pathogenic:3 
- -
The CNGA3 c.67C>T (p.Arg23Ter) stop-gained variant was reported in at least five individuals with achromatopsia or another cone dystrophy, including two homozygotes and three compound heterozygotes, and in two unaffected heterozygous parents of individuals (Johnson et al. 2004; Koeppen et al. 2008; Sundaram et al. 2014; Aboshiha et al. 2014; Zelinger et al. 2015; Huang et al. 2016). The variant was absent from six control individuals and from 100 control chromosomes. The variant is reported at a frequency of 0.00012 in the East Asian population of the Exome Aggregation Consortium, but this is based on only one allele in a region of good sequence coverage so it is presumed to be rare. Based on the evidence and due to the potential impact of stop-gained variants, the p.Arg23Ter variant is classified as pathogenic for achromatopsia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
- -
Achromatopsia    Pathogenic:1 
- -
not provided    Pathogenic:1 
This sequence change creates a premature translational stop signal (p.Arg23*) in the CNGA3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNGA3 are known to be pathogenic (PMID: 14757870, 24903488, 25637600). This variant is present in population databases (rs777509481, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with CNGA3-related conditions (PMID: 14757870, 30682209). ClinVar contains an entry for this variant (Variation ID: 337652). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at